Nature Communications · 2021 · 49 citations · 23 references
Veterinary MedicineImmunologyInfectious DiseasesEarly DetectionImmunology Of Infectious DiseasesOutbreak InvestigationAntibody ScreeningAntigen Detection AssaysDiagnostic ImmunologySerological DiagnosticsSeroprevalence StudiesAntibody Detection TestsAssayDiagnostic Antibody ScreeningSars-cov-2 InfectionSerological Rapid TestsSerological ScreeningSerological SurveillanceSerological Testing For Immunity
In February and March 2020, two mass swab testing campaigns were conducted in Vo', Italy. In May 2020, we tested 86% of the Vo' population with three immuno-assays detecting antibodies against the spike and nucleocapsid antigens, a neutralisation assay and Polymerase Chain Reaction (PCR). Subjects testing positive to PCR in February/March or a serological assay in May were tested again in November. Here we report on the results of the analysis of the May and November surveys. We estimate a seroprevalence of 3.5% (95% Credible Interval (CrI): 2.8-4.3%) in May. In November, 98.8% (95% Confidence Interval (CI): 93.7-100.0%) of sera which tested positive in May still reacted against at least one antigen; 18.6% (95% CI: 11.0-28.5%) showed an increase of antibody or neutralisation reactivity from May. Analysis of the serostatus of the members of 1,118 households indicates a 26.0% (95% CrI: 17.2-36.9%) Susceptible-Infectious Transmission Probability. Contact tracing had limited impact on epidemic suppression.
23
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman, Olfert Landt, Marco Kaiser et al. · Eurosurveillance · 2020 · 8.2K citations · Full text
Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text
Veterinary Medicine, Infectious Diseases, Preventive Medicine +17
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quanxin Long, Xiao-Jun Tang, Q L Shi et al. · Nature Medicine · 2020 · 3.1K citations · Full text